Table 1.
Marker (%) | Time point | Groups (n = 5) | |||
---|---|---|---|---|---|
Blank | PBS | pVAXI | pVAX-EF-1a | ||
CD4+ | Week 0 | 18.01 ± 2.95 | 18.53 ± 2.76 | 18.23 ± 2.85 | 17.98 ± 2.45 |
Week 2 | 18.41 ± 1.85 | 18.55 ± 1.96 | 17.90 ± 2.53 | 28.18 ± 3.05a | |
Week 4 | 18.03 ± 2.84 | 18.80 ± 2.88 | 18.15 ± 1.93 | 30.46 ± 3.59a | |
Week 6 | 18.17 ± 1.54 | 17.93 ± 2.31 | 18.84 ± 1.83 | 32.43 ± 3.23a | |
CD8+ | Week 0 | 8.20 ± 1.55 | 8.13 ± 1.28 | 8.47 ± 1.81 | 8.32 ± 1.65 |
Week 2 | 8.32 ± 1.94 | 8.00 ± 1.48 | 7.94 ± 1.15 | 13.23 ± 2.41a | |
Week 4 | 8.37 ± 2.07 | 8.13 ± 1.58 | 8.25 ± 1.52 | 12.50 ± 3.11a | |
Week 6 | 8.11 ± 1.12 | 8.01 ± 1.54 | 8.27 ± 1.96 | 14.36 ± 1.76a |
Data are presented as the mean ± SD (n = 5). a represents statistically highly significant difference (p < 0.01) as compared with control groups: Blank, PBS and pVAXI